Table 1 Demographic data and clinical characteristics in children with RMPP and NRMPP
Clinical parameters | MPP cases | Controls | P value | RMPP | NRMPP | P value |
|---|---|---|---|---|---|---|
(n = 71) | (n = 22) | (n = 21) | (n = 50) | |||
Age,months | 64.6 ± 32.0 | 62.0 ± 29.2 | 0.733 | 64.5 ± 27.6 | 64.6 ± 34.0 | 0.986 |
Male, n(%) | 29 (40.8) | 11 (50) | 0.449 | 11 (52.4) | 18(36) | 0.2 |
Hospital stay, days | 10.1 ± 4.1 | N/A | 12.6 ± 5.5 | 9.0 ± 2.8 | < 0.001 | |
Duration of fever, days | 8.2 ± 4.4 | N/A | 12.5 ± 3.1 | 6.4 ± 3.4 | < 0.001 | |
pleural effusion, n(%) | 29 (40.8) | N/A | 16 (76.2) | 13 (26) | < 0.001 | |
mucus plug, n(%) | 21 (29.6) | N/A | 15 (71.4) | 6 (12) | < 0.001 | |
expulmonary complications, n(%) | 13 (18.3) | N/A | 7 (33.3) | 6 (12) | 0.047 | |
WBC, 106/L | 9.2 ± 3.7 | N/A | 9.0 ± 1.7 | 9.2 ± 4.2 | 0.766 | |
CRP, mg/L | 14.9 (4.7–34.9) | N/A | 23.3 (10.3–44.6) | 12.8 (4.4–31.3) | 0.03 | |
LDH, IU/L | 480.9 ± 162.5 | N/A | 581.5 ± 179.7 | 437.2 ± 134.4 | 0.001 | |
Lymphocytes in blood | N/A | |||||
CD3+, % | 67.0 ± 9.4 | N/A | 68 ± 8.2 | 66.6 ± 10.0 | 0.595 | |
CD3 + CD4+, % | 36.1 ± 9.3 | N/A | 35.3 ± 7.6 | 36.5 ± 10.0 | 0.654 | |
CD3 + CD8+, % | 26.4 ± 7.2 | N/A | 27.3 ± 6.0 | 26.0 ± 7.6 | 0.494 | |
CD3-CD(16 + 56+), % | 10.9 ± 7.8 | N/A | 9.7 ± 7.7 | 11.4 ± 7.8 | 0.481 | |
CD3-CD19+, % | 19.9 ± 8.5 | N/A | 20.1 ± 7.2 | 19.9 ± 9.1 | 0.904 |